DMAC · DiaMedica Therapeutics Inc.
Market Cap
$364.00M
Shares
53.93M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 8-K | 2026-08-10 | — | |
| 8-K | 2026-05-21 | 2026-05-20 | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| DEF 14A | 2026-04-01 | 2026-05-20 | |
| 8-K | 2026-03-31 | 2026-03-30 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-01-05 | — | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-06 | 2025-08-04 | |
| 8-K | 2025-07-21 | — | |
| 8-K | 2025-07-17 | — | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-03-28 | 2025-05-15 | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-17 | — | |
| 8-K | 2025-03-06 | 2025-02-28 | |
| 8-K | 2025-02-24 | 2025-02-20 | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-06-26 | — | |
| 8-K | 2024-06-26 | 2024-06-25 | |
| 8-K | 2024-05-23 | 2024-05-22 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-04-10 | 2024-04-05 | |
| DEF 14A | 2024-04-04 | 2024-05-22 | |
| 8-K | 2024-03-19 | — | |
| 10-K | 2024-03-19 | 2023-12-31 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-13 | — | |
| 8-K | 2023-09-05 | 2023-09-03 | |
| 8-K | 2023-08-14 | — | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 8-K | 2023-06-21 | — | |
| 8-K | 2023-06-21 | — | |
| 8-K | 2023-06-21 | — | |
| 8-K | 2023-05-30 | — | |
| 8-K | 2023-05-22 | — | |
| 8-K | 2023-05-18 | 2023-05-17 |
Showing 1–50 of 103 filings